Photothermal targeted therapy system and related method integrating preconditioning and automatic triggering of photothermal targeted therapy via measurement of skin surface temperature

The integrated photothermal targeted therapy system addresses tissue damage by using a single light source with preset settings and cooling for precise thermal control, ensuring effective target heating while maintaining epidermal and dermal integrity.

JP7588170B2Active Publication Date: 2024-11-21QUANTA SYST SPA
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
JP2023027134
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2018-10-15
Filing Date
2023-02-24
Publication Date
2024-11-21
Estimated Expiration
2039-06-10

AI Technical Summary

Technical Problem

Existing photothermal targeted therapy methods cause damage to the surrounding dermis and epidermis due to insufficient control over thermal energy application, leading to patient discomfort and tissue damage.

Method used

A photothermal targeted therapy system that integrates preconditioning and photothermal therapy using a single light source with preset power and pulse timing settings, combined with a cooling unit, to selectively heat targets while maintaining the epidermis and dermis below damage thresholds, and includes automatic temperature monitoring and protocol initiation/termination.

Benefits of technology

The system effectively damages embedded targets without harming surrounding tissues by ensuring the epidermis remains below 55°C and targets exceed 55°C, reducing patient discomfort and ensuring precise thermal control.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007588170000001
    Figure 0007588170000001
  • Figure 0007588170000002
    Figure 0007588170000002
  • Figure 0007588170000003
    Figure 0007588170000003
Patent Text Reader

Abstract

A photothermal targeted therapy system for damaging a target embedded in a medium is provided. [Solution] A photothermal targeted therapy system (100) includes a controller (122) and a photothermal therapy unit (120) including a light source. The controller is configured to administer a treatment protocol using the light source at a preset power setting and a preset pulse timing setting. A method for automatically initiating a treatment protocol using the photothermal targeted therapy system includes applying a cooling agent to a treatment location, monitoring a skin surface temperature at the treatment location, and automatically initiating a photothermal therapy protocol when the skin surface temperature reaches a preset threshold. A method for automatically terminating a treatment protocol includes monitoring a skin surface temperature at the treatment location while administering the treatment protocol to the treatment area, and automatically terminating the treatment protocol when the skin surface temperature reaches a preset threshold.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical Field]

[0001] The present invention relates to photothermal targeted therapy, and more particularly to systems and methods for light-induced thermal therapy targeted to specific chromophores or subjects containing specific chromophores embedded in a medium. [Background technology]

[0002] Targets, such as chromophores embedded in a vehicle or subjects containing chromophores, can be thermally damaged by heating the target with a light source, such as a laser. For example, sebaceous glands containing sebum embedded in the dermis can be thermally damaged by heating the sebum with a laser until the sebum itself or the sebaceous glands containing the sebum are damaged. However, applying sufficient thermal energy to damage the target can also damage the surrounding dermis and overlying epidermis, resulting in epidermal and dermal damage as well as pain to the patient.

[0003] Previous approaches to preventing epidermal and dermal damage as well as pain to patients include the following:

[0004] 1. Pre-cooling the epidermis and then applying photothermal therapy.

[0005] 2. Pre-cooling the epidermis and then preconditioning (i.e., pre-heating) the epidermis and dermis with a pre-heating protocol, and then applying photothermal treatment with a separate treatment protocol. In certain cases, the pre-heating protocol and treatment protocol are performed with the same laser, but the two protocols involve different laser settings and application protocols, further complicating the treatment protocol and device. Summary of the Invention [Means for solving the problem]

[0006] According to embodiments described herein, a photothermal target therapy system for damaging a target embedded in a medium includes a controller and a photothermal therapy unit including a light source, the controller configured to administer a therapy protocol, and the therapy protocol is administered using the light source at a preset power setting and a preset pulse timing setting.

[0007] In another embodiment, the treatment protocol includes a preconditioning procedure to preheat the medium and the target, and a photothermal treatment procedure. Both the preconditioning procedure and the photothermal treatment procedure are administered using the light source without changing the preset power settings and preset pulse timing settings between the preconditioning procedure and the photothermal treatment procedure. In a further embodiment, the preconditioning procedure takes a longer duration than the photothermal procedure.

[0008] In yet another embodiment, the system includes a cooling unit, and the treatment protocol further includes a cooling procedure before and during the treatment protocol. In yet another embodiment, in both the preconditioning procedure and the photothermal treatment procedure, the light source is configured to emit a series of light pulses at a preset power level, a preset pulse length, and a preset pulse interval.

[0009] In yet another embodiment, the preconditioning and photothermal therapy procedures involve the application of light pulses in a scanning manner over a predefined region, which in an exemplary embodiment is a 2x2 matrix of 5mm x 5mm treatment blocks.

[0010] In a further embodiment, during the preconditioning and photothermal therapy procedures, the temperature in the medium is below the denaturation and damage threshold of the medium, and the target is heated to a temperature above the damage threshold of the target. In an exemplary embodiment, the temperature of the medium (e.g., the epidermis) is below 55° C., and the target is heated to a temperature above 55° C. In another embodiment, the temperature of the medium is adjusted depending on the location of the treatment area on the patient.

[0011] In another embodiment, a method of using a photothermal targeted therapy system to damage a target embedded in a medium is disclosed. The system includes a light source. The method includes defining a set of parameters for a series of light pulses emitted by the light source, the set of parameters including a preset power level, a preset pulse length, a preset pulse interval, and a number of light pulses. The method also includes generating the series of light pulses according to the defined set of parameters and administering the series of light pulses to the medium.

[0012] In yet another embodiment, the method further includes cooling the medium while administering the treatment protocol. In yet another embodiment, applying the series of light pulses includes defining the predetermined region as a 2x1 or greater matrix of treatment blocks. In an exemplary embodiment, applying the series of light pulses includes defining the predetermined region as a 2x2 matrix of 5 millimeter by 5 millimeter treatment blocks.

[0013] In further embodiments, administering the train of light pulses includes applying the train of light pulses such that the temperature of the medium is below the denaturation and damage threshold of the medium, and the target is heated to a temperature above the damage threshold of the target. In an exemplary embodiment, administering the train of light pulses includes raising the temperature of the medium (e.g., the epidermis) below 55°C while heating the target to a temperature above 55°C.

[0014] According to embodiments described herein, a method for automatically initiating a treatment protocol using a photothermal targeted therapy system is described, the method including applying a cooling mechanism to a treatment location, monitoring a skin surface temperature at the treatment location, and automatically initiating a treatment protocol when the skin surface temperature reaches a preset threshold.

[0015] In a further embodiment, the treatment protocol is initiated without any manual input by the user.

[0016] According to another embodiment, a method for automatically terminating a treatment protocol using a photothermal targeted therapy system is described, the method including monitoring a skin surface temperature at a treatment location during administration of a treatment protocol to a treatment area, and automatically terminating the treatment protocol when the skin surface temperature reaches a preset threshold.

[0017] According to a further embodiment, the treatment protocol is terminated without any manual input by the user.

[0018] Additional and various modifications of the proposed embodiment are described hereinafter. [Brief explanation of the drawings]

[0019] [Figure 1] 1 illustrates an exemplary photothermal targeted therapy system according to an embodiment. [Figure 2] 1 illustrates an exemplary scanner configuration for use in a photothermal targeted therapy system according to an embodiment. [Figure 3] 1 illustrates an exemplary therapeutic matrix configuration according to certain embodiments. [Figure 4] FIG. 1 shows a schematic diagram of an exemplary set of light pulses suitable for use in a treatment protocol or an integrated preconditioning / light treatment protocol according to certain embodiments. [Figure 5] 10 shows the estimated temperature of a targeted sebaceous gland as a function of time upon application of a therapeutic light pulse according to an embodiment. [Figure 6] 10 shows the measured temperature of the skin surface as a function of time during a treatment protocol according to an embodiment. [Figure 7] 1 shows a flowchart illustrating an exemplary process for analyzing measured skin surface temperature during the cooling portion of a treatment protocol and then initiating the treatment protocol accordingly. [Figure 8] 1 shows a flowchart illustrating an exemplary process for continuing to analyze measured skin surface temperature during a treatment protocol and then terminating the treatment protocol accordingly. DETAILED DESCRIPTION OF THE INVENTION

[0020] Embodiments of the present invention are described more fully hereinafter with reference to the accompanying drawings, in which embodiments of the invention are shown. However, this invention may be embodied in many different forms and should not be construed as limited to the embodiments set forth herein. Rather, these embodiments are provided so that this disclosure will be thorough and complete, and will fully convey the scope of the invention to those skilled in the art. In the drawings, the sizes and relative sizes of layers and regions may be exaggerated for clarity. Like numbers refer to like elements throughout.

[0021] Although terms such as first, second, third, etc. may be used herein to describe various elements, components, regions, layers, and / or sections, it should be understood that these elements, components, regions, layers, and / or sections are not intended to be limited by these terms. These terms are used only to distinguish one element, component, region, layer, or section from another region, layer, or section. Thus, a first element, component, region, layer, or section discussed below could be referred to as a second element, component, region, layer, or section without departing from the teachings of the present invention.

[0022] For ease of explanation, spatially relative terms such as "below," "below," "belowside," "below," "above," and "upper" may be used herein to describe the relationship of one element or feature to another element or feature illustrated in the figures. It should be understood that spatially relative terms are intended to encompass various orientations of the device during use or operation in addition to the orientation shown in the figures. For example, if the device in the figures were inverted, an element described as "below" or "below" or "below" another element or feature would be oriented "above" the other element or feature. Thus, the exemplary terms "below" and "below" can encompass both an orientation above and below. A device may be otherwise oriented (rotated 90 degrees or at other orientations) and the spatially relative descriptors used herein should be interpreted accordingly. Additionally, when a layer is referred to as being "between" two layers, it should also be understood that this may be the only layer between the two layers or that one or more intervening layers may also be present.

[0023] The terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. As used herein, the singular forms "a," "an," and "the" are intended to include the plural forms as well, unless the context clearly indicates otherwise. It is further understood that the terms "comprises" and / or "comprising," as used herein, specify the presence of the specified features, integers, steps, operations, elements, and / or components, but do not preclude the presence or addition of one or more other features, integers, steps, operations, elements, components, and / or groups thereof. As used herein, the term "and / or" includes one or more of the associated listed items in any combination and may be abbreviated as " / ."

[0024] When an element or layer is referred to as "on," "connected to," "coupled to," or "adjacent to" another element or layer, it is understood that it can be directly on, directly connected to, coupled to, or adjacent to the other element or layer, or that intervening elements or layers can be present. In contrast, when an element is referred to as "directly on," "directly connected to," "directly coupled to," or "directly adjacent to" another element or layer, there are no intervening elements or layers. Similarly, when light is received or provided "from" an element, it can be received or provided directly from that element or from an intervening element. On the other hand, when light is received or provided "directly from" an element, there are no intervening elements.

[0025] Embodiments of the present invention are described herein with reference to cross-sectional illustrations that are schematic illustrations of idealized embodiments (and intermediate structures) of the present invention. Accordingly, variations from the shapes of the illustrations are to be expected as a result, for example, of manufacturing techniques and / or tolerances. As such, embodiments of the present invention should not be construed as limited to the particular shapes of regions illustrated herein but include deviations in shapes that result, for example, from manufacturing. Thus, the regions illustrated in the figures are schematic in nature and the shapes are not intended to illustrate the actual shapes of regions of a device and are not intended to limit the scope of the present invention.

[0026] Unless otherwise defined, all terms (including scientific and technical terms) used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Terms as defined in commonly used dictionaries should be interpreted as having a meaning consistent with their meaning in the context of the relevant art and / or this specification, and should not be interpreted in an idealized or overly formal sense unless specifically defined herein.

[0027] 1 shows an exemplary photothermal targeted therapy system for damaging a target, such as a subject, containing a particular chromophore or chromophore embedded in a medium and for heating the target to a temperature high enough to damage the target without damaging the surrounding medium. The system can be used, for example, for targeted photothermal ablation of sebaceous glands containing sebum as the chromophore without damaging the epidermis and dermis surrounding the target gland.

[0028] 1 , photothermal targeted therapy system 100 includes cooling unit 110 and light therapy unit 120. Cooling unit 110 provides cooling means for cooling the treatment area, i.e., the outer skin layer area overlying the targeted sebaceous glands, such as by contact or direct air cooling. Cooling unit 110 is connected to a controller 122 within light therapy unit 120. While controller 122 is shown contained within light therapy unit 120 in FIG. 1 , it should be noted that the controller may be located outside both cooling unit 110 and light therapy unit 120, or even within cooling unit 110.

[0029] The controller 122 further controls other components within the light therapy unit 120, such as the laser 124, display 126, temperature monitoring unit 128, foot switch 130, door interlock 132, and emergency on / off switch. The laser 124 provides the laser power for the light therapy protocol, and the controller 122 adjusts specific settings for the laser, such as output power and pulse time. The laser 124 can be a single laser or a combination of two or more lasers. When two or more lasers are used, the laser outputs are optically combined to function as one more powerful laser. The display 126 can include information such as the operating status of the cooling unit 110, the laser 124, and other system status. The temperature monitoring unit 128 is used, for example, to monitor the temperature of the skin surface of the treatment area, and the measured skin surface temperature of the treatment area is used by the controller 122 to adjust the light therapy protocol. The controller 122 also interfaces with a foot switch 130 for remotely turning the laser 124 and / or the cooling unit 110 on or off. Additionally, the door interlock 132 can be used as an additional safety measure so that if the door to the treatment room is partially open, the door interlock 132 detects the condition and instructs the controller 122 to not operate the phototherapy unit 120, or at least the laser 124. Additionally, an emergency on / off switch 134 can be provided to quickly shut down the photothermal targeted therapy system 100 in the event of an emergency. In another modification, an additional photodiode or other sensor can be added to monitor the power level of the energy emitted by the laser 124.

[0030] Continuing with reference to FIG. 1 , photothermal targeted therapy system 100 further includes a handheld scanner 160, which is the portion of the device held in a user's hand when applying a treatment protocol to a patient. Scanner 160 can be formed, for example, in a gun-like or stick-like shape for ease of holding by a user. Scanner 160 is connected to cooling unit 110 via cooling connection 162 so that the scanner 160 can be used to apply a cooling protocol. Additionally, output from laser 124 is connected to scanner 160 via fiber optic delivery 164 so that the scanner 160 can be used to apply a phototherapy protocol. Optionally, scanner 160 is connected to temperature monitoring unit 128 via temperature connection 166, for example, to provide feedback of the skin temperature of the treatment area to controller 122.

[0031] 1 , the light treatment unit 120 of the photothermal targeted therapy system 100 provides light energy at a single setting used for both preconditioning the treatment area as well as light treatment of the targeted sebaceous glands. That is, rather than sequentially providing an application of light energy optimized for preconditioning followed by a different application of light optimized for light treatment, the light treatment unit 120 provides light energy used for both preconditioning and light treatment in a single sequential application protocol without changing the light energy setting. This integrated protocol reduces the time and complexity involved in applying light treatment.

[0032] FIG. 2 shows further details of the scanner 160 according to one embodiment. The cooling connection 162 is connected to a cooling delivery unit 202 configured to deliver a cooling means (e.g., a cold air stream) to the treatment area. The fiber optic delivery 164 from the laser 124 is connected to a laser energy delivery unit 204, which includes optical components for delivering light energy to the treatment area for a photothermal therapy protocol. Finally, the temperature connection 166 is connected to a temperature sensor 206 that measures the temperature of the treatment area for feedback to the controller 122. Additionally, the scanner 160 includes an on / off switch 210 (e.g., a trigger switch that turns the laser 124 on and off) and, optionally, a status indicator 212 that indicates the operating status of the scanner 160, such as when the laser is operating. While the scanner 160 is shown schematically as a box in FIG. 2, the actual shape may be configured for ease of use. For example, the scanner 160 can be shaped as a nozzle with a handle, a handgun shape, or any other suitable shape to facilitate user aiming and control.

[0033] In an exemplary method according to one embodiment, a cooling protocol is applied to the entire treatment area. The cooling protocol may include, for example, application of a cold air stream across the treatment area for a specified period of time, such as 10 seconds. After cooling, the cooling means (e.g., the cold air stream) remains active, and a light treatment protocol is applied to the treatment area. In one embodiment, a square "flat-top" beam of pulses is used in combination with a scanner device to sequentially apply laser pulses to segments within the treatment area. According to one embodiment, the light treatment protocol includes application of a set number of light pulses to each segment of the treatment area, sequentially applying laser pulses to different segments. In another embodiment, the laser pulses are applied to the segments in a random order.

[0034] In a typical use scenario, the entire treatment area covering the sebaceous glands to be treated is cooled. A virtual grid configuration is provided over the treatment area as shown in FIG. 3. Exemplary grid configuration 300 includes 12 blocks arranged in a 3×4 matrix. Many other grid configurations are possible, e.g., 1×1, 2×1, 2×2, etc. In the example shown, the treatment area is defined as a 2×2 block including blocks 310, 312, 324, and 326 (numbered 5, 6, 8, and 9, respectively).

[0035] In an exemplary method according to one embodiment, a cooling protocol is applied to the entire treatment area (i.e., blocks 310, 312, 324, and 326) in the grid configuration 300. The cooling protocol may include the application of a cold air stream across the treatment area for a predetermined period of time, such as 10 seconds. After cooling, the cooling means (e.g., the cold air stream) remains active, and a preconditioning and light treatment protocol is applied to the treatment area. In one embodiment, a square "flat-top" beam of pulses is used in combination with a scanner device to sequentially apply laser pulses to blocks 310, 312, 324, and 326. According to one embodiment, the integrated preconditioning / light treatment protocol includes the application of a set number of light pulses to each of the blocks in the treatment area, pulsing the blocks sequentially. In another embodiment, the blocks are pulsed in a random order.

[0036] An example of a pulse set suitable for a treatment protocol or an integrated preconditioning / light treatment protocol is illustrated in FIG. 4 , according to one embodiment. Sequence 400 includes light pulses 422, 424, 426, 428, 430, 432, and 434 applied to one of the blocks within the treatment region. In one embodiment, all seven light pulses are of equal power, separated by uniform pulse separation (represented by double arrow 442), and have the same pulse duration (represented by gap 444). In one example, pulse duration 444 is 150 milliseconds, and pulse separation is 2 seconds. The 2-second pulse separation is intended to cool the epidermis and dermis of the block to prevent damage. During the pulse separation time, the laser can be scanned across different blocks within the treatment region to increase laser usage efficiency. Note that FIG. 4 is not drawn to scale. Other configurations of laser pulses are possible, such as gradually increasing the power over multiple pulses or varying the laser pulse parameters (e.g., pulse duration, pulse separation, and / or peak power) over multiple pulses. It is recognized that there are various other pulse trains that achieve the same average energy deposited in the skin tissue while maintaining a short pulse duration.

[0037] Figure 5 shows the estimated temperature of the skin surface in a treatment area when light pulses such as those shown in Figure 4 are applied according to one embodiment. In the example shown in Figure 5, the treatment area was cooled with direct air cooling for 7 seconds, and then, while maintaining the cooling, a light pulse was applied for 2 seconds from a 1726 nm wavelength laser at 22 watts of power and 150 milliseconds duration. In this particular example, the direct air cooling used for cooling and during the treatment protocol delivered a high-velocity air column cooled to -22°C, resulting in a current of approximately 350 W / m between the skin and the air. 2 yielding a heat transfer coefficient of K.

[0038] The beam size is 4.9 mm in one embodiment. 24. The exact beam size can be adjusted, for example, using collimation optics, depending on the size of the treatment area, the power profile of the laser, the location of the treatment area on the body, and other factors. Furthermore, the average laser power per area should be balanced with the heat removal achieved by the cooling system. The resulting measured skin surface temperature change is shown in graph 500, where peak 522 corresponds to applied light pulse 422 shown in FIG. 4, as well as peaks 424, 426, 428, and 430.

[0039] Because long pulse durations can soften temperature peaks through diffusion, pulse durations should be short enough to allow for rapid temperature rise in targets such as sebaceous glands. It is recognized that various other pulse trains exist that achieve the same average energy deposited in skin tissue while maintaining short pulse durations. In the example shown in FIG. 5, the average power per spot is 22 W × 0.15 s / 2 s = 1.65 W. The same average power per spot can be achieved, for example, by pulsing 33 Watts for 100 ms with a 2 s pulse separation or pulsing 25.1 W for 125 ms with a 1.9 s pulse separation. Furthermore, the average laser power per area should be balanced with the heat removal achieved by the cooling system.

[0040] 4 and 5, it can be seen that light pulses 422, 424, 426, and 428 essentially provide a preconditioning effect, as the target temperature increases from approximately 40° C. at peak 522 to approximately 57° C. at peak 528. Pulse 434 thus brings the temperature of the chromophore-containing target (i.e., the sebum-containing sebaceous gland) above its damage threshold to approximately 61° C. at peak 534. In this way, by simply repeatedly applying light pulses with the same characteristics, the preconditioning and phototherapy protocols are effectively integrated, eliminating the need for separate preconditioning systems and protocols distinct from the phototherapy systems and protocols.

[0041] Also, note that the number of light pulses applied for preconditioning purposes is slightly greater than the number of light pulses used for light therapy. This characteristic is the opposite of existing photothermal targeted therapy systems, which attempt to minimize the time required for preconditioning due to the difficulty of balancing the cooling and preconditioning effects on pain management during treatment. The systems and methods described herein use the same light pulse settings for preconditioning as for light therapy, thereby eliminating the problem of minimizing preconditioning time.

[0042] Successful photothermal treatment of a specific target with reduced patient discomfort may include: 1) sparing the epidermis, i.e., peak epidermal temperature values ​​less than about 55° C.; 2) sparing the dermis, i.e., avoiding overheating of the dermis by balancing the average power of the treatment pulses with the heat removal of the cooling system; and 3) selective heating of the target, e.g., peak temperatures above 55° C. for sebaceous gland treatment. Additionally, overcooling the treatment area during the cooling phase should be avoided to prevent cold damage (e.g., frostbite) to the epidermis.

[0043] Note that the number of pulses applied during a photothermal treatment protocol can range from 2 pulses to approximately 100 pulses, depending on variables such as cooling effectiveness, laser power, pulse width, and pulse frequency.

[0044] Alternatively, a raster scanning process can be used to scan a continuous wave laser beam across the treatment area, rather than applying a laser pulse to a particular block and then moving the laser to another block to apply another laser pulse. In this case, using raster scanning, the temperature rise of a target such as a sebaceous gland can be calculated as the convolution of the size of the sebaceous gland and the speed of the beam.

[0045] It is well known in the literature that tissue parameters such as epidermal and dermal thickness vary between individuals and even between different skin locations due to factors such as age, sex, ethnicity, pH, oil content, and hydration. For example, the forehead has different tissue properties than the occipital region, even within the same individual, necessitating different treatment parameter settings at different treatment locations. While existing treatment protocols are based on a "one-treatment-fits-all" approach, such variations in tissue properties when determining a specific treatment protocol can significantly impact the effectiveness of laser-based acne treatments. Additionally, manufacturing variability and operating conditions can cause variations in the exact laser power, spot size, cooling capacity, and so on between specific laser systems. Reducing treatment variability, which can result from variations in the laser power output of a particular machine as well as variations in treatment conditions such as ambient humidity and temperature, helps achieve more consistent treatment results. In other words, reducing variability between photothermal treatments improves safety and increases efficacy.

[0046] In one embodiment, any variation in skin surface temperature at the start of a photothermal treatment protocol affects the thermal transfer of laser pulse energy to the target. For example, in Figure 6, the treatment protocol shown cooled the skin surface to approximately -7°C when the first laser pulse was applied, but if the skin was cooler or warmer, the initial peak (i.e., peak 624) would have reached a different temperature, affecting the overall temperature rise during subsequent laser pulse applications.

[0047] In existing photothermal therapy systems, this variation in skin surface temperature at the start of a photothermal therapy protocol is unavoidable because the cooling procedure involves the application of a cooling means (e.g., cold air or a cooled surface) for a preset period of time. For example, the user may be instructed to have the photothermal therapy system apply a stream of cold air to the treatment area for a certain number of seconds, and then be prompted to begin the photothermal therapy protocol, which includes the application of laser pulses. However, this process does not take into account the potential for variation in the performance of the photothermal therapy system, as well as the thermal coefficient of the skin surface in the treatment area, resulting in unavoidable variability in treatment efficacy.

[0048] In some embodiments, the method of administering the treatment includes monitoring the skin surface temperature during cooling and automatically triggering the preconditioning and photothermal treatment protocol without user intervention when a threshold skin surface temperature is reached.

[0049] This cooling monitoring and automatic treatment protocol triggering can be performed, for example, by incorporating temperature measurements using commercially available, off-the-shelf, low-cost sensors (see, e.g., temperature sensor 206 in FIG. 2 ) that can be incorporated into scanners held by medical professionals to apply treatment to patients, or by incorporating temperature measurements using separate commercially available, off-the-shelf single- or multi-pixel thermal measurement devices. The monitoring process can be performed at a very local level to adjust the timing of treatment protocol initialization on the fly. In this way, a treatment protocol can be specified to provide a cooling effect appropriate for patient comfort while maintaining epidermal and dermal temperatures above the damage threshold during the cooling phase.

[0050] Turning to FIG. 7, there is a flowchart illustrating an exemplary process for cooling monitoring and automatic initiation of a light treatment protocol, according to one embodiment. As shown in FIG. 7, the automatic treatment initiation process 700 begins by powering on the system at initialization step 710, followed by application of a cooling means to the treatment area at step 712. The cooling means may be, for example, a stream of cold air. The skin surface temperature of the treatment area is then measured at step 714. Temperature measurement may be performed, for example, using a low-speed infrared camera or similar device. A determination is then made at decision 716 whether the measured skin surface temperature is sufficiently low to initiate application of the treatment protocol (e.g., -5°C or other pre-set temperature setting). If decision 716 is answered negatively, the process returns to step 712 to continue application of the cooling means to the treatment area.

[0051] If decision 716 is answered in the affirmative, the automatic treatment initiation process 700 proceeds to automatically initiate the treatment protocol without user intervention at step 718. The automatic treatment initiation process ends at step 720.

[0052] Optionally, for safety and control reasons, the current skin surface temperature can be compared to stored thresholds adapted to various control parameters. Monitoring of the skin surface temperature of the treatment area can continue throughout the treatment protocol and even after application of the laser pulses has ended, so that if application of the cooling means to the treatment area continues, application of the cooling means can be stopped once the measured epidermal temperature reaches, for example, room temperature or other pre-set post-treatment temperature setting.

[0053] An optional additional process for automatically terminating a treatment protocol without human intervention is illustrated in Figure 8. As shown in Figure 8, the automatic treatment termination process 800 begins with step 810 to initiate a light treatment protocol. Step 810 may be, for example, light treatment initiation step 718 of Figure 7. Alternatively, the automatic treatment termination process 800 is applicable to the use of any light treatment protocol, regardless of the treatment protocol initiation method.

[0054] Continuing with reference to FIG. 8 , the automatic treatment termination process 800 proceeds to step 812 to apply a set of laser pulses to the treatment area. During or immediately after the application of the set of laser pulses, the skin surface temperature of the treatment area is measured in step 814. A decision 816 is then made to determine whether the measured skin surface temperature is above a preset threshold temperature (i.e., too hot). If decision 816 is answered in the affirmative, the automatic treatment termination process proceeds to step 818 to automatically terminate the light treatment protocol without further user intervention. The laser is disabled in step 822, and the process ends in step 830. If decision 816 is answered in the negative, the treatment protocol continues to decision 840 to determine whether the treatment protocol has ended. If decision 840 is answered in the negative, the process returns to step 812 to continue applying additional laser pulses to the treatment area. For example, if the treatment protocol is defined as the application of eight laser pulses to a particular treatment area, and only seven or fewer laser pulses have been applied to that point, additional laser pulses will be triggered as long as the skin surface temperature remains below the damage threshold. If decision 840 is answered in the affirmative, the process proceeds to steps 818, 822, and 830 to terminate the treatment protocol without further user intervention.

[0055] 8 , application of cooling means to the treatment area can optionally continue via steps 812, 814, 816, 818, and / or 840 to mitigate the possibility of overheating the treatment area. In one example, for a larger treatment area (e.g., a 2×2 matrix of 5 mm×5 mm treatment blocks), a set number of laser pulses (e.g., in the range of 1 to 8) are applied sequentially to each treatment block. For example, step 812 of applying laser pulses includes application of one laser pulse to the first treatment block in some embodiments. In step 814, the skin surface temperature is measured, and if the measured skin surface temperature is below a preset threshold and the light treatment protocol includes application of additional pulses, the process returns to step 812, where additional laser pulses are applied to the treatment area. Then, in one example, a second laser pulse is applied to the first treatment block, or the laser aim is moved to the second treatment block and a laser pulse is applied thereto. The laser aim can be moved after each laser pulse, or successive laser pulses can be applied to a single treatment block before the laser aim is focused on the second treatment block. For example, if there is a time delay of up to 2 seconds between the application of laser pulses, a temperature reading of the treatment area can be taken during the time delay to make a decision as to whether to apply additional laser pulses. In one embodiment, treatment parameters such as laser power, laser beam size, treatment area dimensions, and the number of laser pulses applied per treatment block are predefined by the user, but an automatic treatment termination process allows for real-time, ad-hoc adjustments to the treatment protocol to reduce the potential for damage to the treatment area even without user intervention.

[0056] The foregoing is illustrative of the present invention and is not to be construed as limiting thereof. While several exemplary embodiments of the present invention have been described, those skilled in the art will readily recognize that numerous modifications of the exemplary embodiments are possible without substantially departing from the novel teachings and advantages of the present invention. For example, lasers having other wavelengths, such as about 1210 nm, can be used. An important aspect of the embodiments described herein is increased patient safety by automating the initiation and / or termination of treatment protocols to reduce the likelihood of tissue damage due to operator error.

[0057] Thus, many different embodiments can be derived from the foregoing description and drawings. It is understood that literally describing and illustrating every combination and subcombination of these embodiments would be unduly repetitive and ambiguous. Accordingly, the specification, including the drawings, shall be construed as describing all combinations and subcombinations of the embodiments described herein, and modes and processes for making and using them, and shall support any claim to any such combination or subcombination.

[0058] This disclosure includes the following items, which are part of this disclosure:

[0059] Item 1. A photothermal target therapy system for damaging a target embedded in a medium, the system including a controller and a photothermal therapy unit including a light source, the controller configured to administer a treatment protocol, and the treatment protocol is administered using the light source at a preset power setting and a preset pulse timing setting.

[0060] Item 2. The system described in Item 1, wherein the treatment protocol includes a preconditioning procedure for preheating the medium and a photothermal treatment procedure, and both the preconditioning procedure and the photothermal treatment procedure are administered using the light source without changing the preset power setting and the preset pulse timing setting between the preconditioning procedure and the photothermal treatment procedure, and the preconditioning procedure takes a longer duration than the photothermal procedure.

[0061] Item 3. The system of item 2, further comprising a cooling unit, wherein the treatment protocol further comprises a cooling step for cooling the medium while administering the treatment protocol.

[0062] Item 4. The system of item 3, wherein in both the preconditioning procedure and the photothermal therapy procedure, the light source is configured to emit a series of light pulses at a preset power level, a preset pulse length, and a preset pulse interval.

[0063] Item 5. The system of item 4, wherein the preset power level is within the range of 10 watts to 50 watts per pulse.

[0064] Item 6. The system according to Item 4, wherein the preset pulse length is within the range of 25 milliseconds to 200 milliseconds per pulse.

[0065] Item 7. The system according to Item 4, wherein the preset pulse interval is within a range of 0.5 seconds to 2.5 seconds.

[0066] Item 8. The system of item 4, wherein the preconditioning procedure and the photothermal therapy procedure include applying light pulses in a scanning manner over a pre-defined area.

[0067] Item 9. The system of item 8, wherein the predetermined region is a 2x1 or larger matrix of treatment blocks.

[0068] Item 10. The system of item 8, wherein the predefined region is a 2x2 matrix of 5 millimeter x 5 millimeter treatment blocks.

[0069] Item 11. The system of item 4, wherein during the preconditioning procedure and the photothermal therapy procedure, the temperature of the medium is below the damage threshold of the medium and the target is heated to a temperature above the damage threshold of the target.

[0070] Item 12. The system of item 11, wherein during the preconditioning procedure and the photothermal therapy procedure, the temperature of the medium is less than 55°C and the target is heated to a temperature greater than 55°C.

[0071] Item 13. The system of item 11, further comprising a temperature monitor for measuring the temperature of the medium as the series of light pulses is applied to the medium.

[0072] Item 14. A method of using a photothermal target therapy system to damage a target embedded in a medium, the system including a light source, the method including: 1) defining a set of parameters for a series of light pulses emitted by the light source, the set of parameters including a preset power level, a preset pulse length, a preset pulse interval, and a number of light pulses; 2) generating the series of light pulses according to the defined set of parameters; and 3) administering the series of light pulses to the medium.

[0073] Item 15. The method of item 14, further comprising cooling the medium before subjecting the medium to the series of light pulses, to cool the medium before and while subjecting the medium to the series of light pulses.

[0074] Item 16. The method of item 15, wherein applying the series of light pulses includes defining a predetermined region as a 2x1 or greater matrix of treatment blocks.

[0075] Item 17. The method of item 16, wherein applying the series of light pulses includes defining a predetermined region as a 2x2 matrix of 5 millimeter x 5 millimeter treatment blocks.

[0076] Item 18. The method of item 14, wherein administering the series of light pulses includes applying the series of light pulses such that the temperature of the medium is below the damage threshold of the medium and the target is heated to a temperature above the damage threshold of the target.

[0077] Item 19. The method of item 14, wherein administering the series of light pulses comprises heating the target to a temperature above 55°C while raising the temperature of the medium to below 55°C.

[0078] Item 20. The method of item 14, further comprising monitoring the temperature of the medium as the series of light pulses is applied to the medium.

[0079] Item 21. A method of automatically initiating a treatment protocol using a photothermal targeted therapy system, the method comprising: applying a cooling means to a treatment location; monitoring a skin surface temperature at the treatment location; and automatically initiating the treatment protocol when the skin surface temperature reaches a preset threshold.

[0080] Item 22. The method of item 21, wherein automatically initiating the treatment protocol is performed without any manual input by a user.

[0081] Item 23. A method for automatically terminating a treatment protocol using a photothermal targeted therapy system, the method comprising: monitoring a skin surface temperature at a treatment location during administration of the treatment protocol to a treatment area; and automatically terminating the treatment protocol when the skin surface temperature reaches a preset threshold.

[0082] Item 24. The method of item 23, wherein automatically terminating the treatment protocol is performed without any manual input by a user.

[0083]

[0023] Embodiments of the present invention are disclosed herein, and although specific terms are employed, they are used in a generic and descriptive sense only and not for purposes of limitation. While several exemplary embodiments of the present invention have been described, those skilled in the art will readily appreciate that many modifications of the exemplary embodiments are possible without materially departing from the novel teachings and advantages of the present invention. All such modifications are therefore intended to be included within the scope of the present invention as defined in the claims. Accordingly, the foregoing are illustrative of embodiments of the present invention and should not be construed as limited to the specific embodiments disclosed. It should be understood that modifications of the disclosed embodiments, as well as other embodiments, are intended to be included within the scope of the appended claims. The present invention is defined solely by the following claims and the full scope of their equivalents.

Claims

1. 1. A control device for a photothermal targeted therapy system for damaging a target implanted in the epidermis, the photothermal targeted therapy system including a laser, The control device controls: 1) defining a set of parameters for a series of laser pulses emitted by the laser, the set of parameters including a preset power level, a preset pulse length, a preset pulse interval, and a number of laser pulses; 2) generating the series of laser pulses according to the defined set of parameters; 3) applying the series of laser pulses to the epidermis according to a treatment protocol including application of laser pulses over a preset area including a 2×1 or greater matrix of treatment blocks, and an application sequence for applying multiple laser pulses to each of the treatment blocks; and 4) turning the laser on and off. the laser is configured to emit a series of laser pulses at the preset pulse intervals; The control device, applying a cooling means to cool the epidermis over the entirety of the predetermined area; monitoring a surface temperature of the epidermis; automatically initiating the treatment protocol when the epidermal surface temperature reaches a preset threshold; Control the The control device, monitoring the temperature of the epidermis while administering the treatment protocol to the treatment area; determining whether the temperature of the epidermis is below a predetermined damage threshold of the epidermis during the pulse interval, and turning on the laser if it is determined that the temperature is below the damage threshold; automatically terminating the treatment protocol when it is determined that the epidermis surface temperature has reached the damage threshold; A control device that controls the above.

2. The control device of claim 1, wherein the control device moves the laser aim to a different treatment block of the matrix during the pulse interval.

3. The control system of claim 1 , further comprising cooling the epidermis before and while applying the series of laser pulses to the epidermis.

4. 4. The control device of claim 3, wherein administering the series of laser pulses comprises applying the series of laser pulses such that a temperature of the epidermis is below a damage threshold of the epidermis and such that the target is heated to a temperature above a damage threshold of the target.

5. The control device of claim 3 , wherein applying the series of laser pulses comprises raising the temperature of the epidermis to less than 55° C. while heating the target to a temperature greater than 55° C.

6. The control system of claim 3 , further comprising monitoring a temperature of the epidermis as the series of laser pulses are applied to the epidermis.

7. The control device of claim 1 , wherein automatic initiation of a photothermal therapy protocol in response to the epidermal surface temperature reaching the preset threshold is performed without manual input by a user.

8. The control device of claim 1 , wherein automatically terminating the treatment protocol is performed without manual input by a user.

9. The control device of claim 1, wherein the predetermined pulse length is within the range of 25 milliseconds to 200 milliseconds per pulse.

10. A control device as claimed in any one of claims 1 to 9, wherein the predetermined pulse interval is within a range of 0.5 seconds to 2.5 seconds.

Citation Information

Patent Citations

  • tissue therapy device

    JP2001514057A

  • System For Electromagnetic Radiation Dermatology And Head For Use Therewith

    US20090137995A1

  • Methods and devices for non-ablative laser treatment of dermatologic conditions

    US20100222853A1

  • Tissue optical clearing devices for subsurface light-induced phase-change and method of use

    US20120010603A1

  • Variable Intensity Laser Treatments of the Skin

    US20140121631A1